期刊文献+

并发神经精神狼疮的狼疮肾炎患者生存分析 被引量:1

Survival analysis of lupus nephritis with neuropsychiatric systemic lupus erythematosus
原文传递
导出
摘要 目的探讨并发神经精神狼疮(NPSLE)的狼疮肾炎(LN)患者的生存率及其影响因素。方法收集78例并发NPSLE的LN患者的临床及实验室资料,共59个变量。对患者进行随访,随访起点为NPSLE起病,随访终止目标为患者因系统性红斑狼疮(SLE)或其并发症死亡,平均随访时间(53.26~44.32)月。用Kaplan—Meier法计算累积生存率,并以Cox回归模型进行影响因素分析。结果78例患者中16例(20.5%)因SLE或其并发症死亡。感染为最常见的死亡原因,占31.3%。患者1年、3年、5年和10年的累计总生存率分别为83.2%、81.7%、76.7%和76.7%。对生存率有影响的危险性因素为高血压(RR=6.965,95%CI:1.578—30.746,P:0.010)、肺部感染(RR:8.171,95%C1:1.954~34.177,P=0.004)及急性肾衰竭(RR=6.978,95%CI:2.063~23.609,P=0.002);保护性因素为环磷酰胺(CTX)冲击治疗(RR=0.130,95%CI:0.031—0.541,P=0.005)和NPSLE治疗缓解(RR=0.169,95%CI:0.042~0.679,P=0.012)。结论感染是并发NPSLE的LN患者最常见的死亡原因。并发NPSLE的LN患者的生存率低于单纯发生LN或NPSLE患者的生存率。高血压、肺部感染及急性。肾衰竭是死亡的危险因素;CTX冲击治疗和NPSLE治疗缓解能降低病死率,改善预后。 Objective To investigate the survival rate and the influencing factors in lupus nephritis (LN) patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Methods Clinical characteristics and biochemical markers of 78 patients including 59 variances were analyzed. Patients were followed up from the onset of NPSLE to death. Patient survival rate was estimated by Kaplan-Meier method. Cox regression model was used to analyze influencing factors. Results Sixteen (20.5%) of 78 patients died of SLE or its complications, Infection was the main cause of death (31.3%). One-, 3-, 5- and 10-year survival rates were 83.2%, 81.7%, 76.7% and 76.7%, respectively. Hypertension (RR =6.965,95%CI:1.578-30.746, P= 0.010), pulmonary infection (RR =8.171,95% CI: 1.954-34.177, P=0.004)and acute renal failure (RR=6.978,95%CI: 2.063-23.609, P=0.O02) were risk factors of mortality, while cyclophosphamide (CTX) impulse therapy(RR=O.130,95%CI:0.031-0.541, P=0.005) and resolution of NPSLE(RR= 0.169, 95%CI: 0.042-0.679, P=O.012)were protective factors. Conclusions Infection is the main cause of death in patients of LN complicated with NPSLE. Survival rate of LN patients with NPSLE in this study is lower than those of LN and NPSLE alone reported by other authors.Hypertension, pulmonary infection and acute renal failure are risk factors of mortality, while CTX impulse therapy and resolution of NPSLE reduce the mortality and improve the prognosis.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2008年第11期792-796,共5页 Chinese Journal of Nephrology
基金 广东省自然科学基金(7001608)
关键词 狼疮肾炎 狼疮血管炎 中枢神经系统 生存率 COX回归模型 Lupus nephritis Lupus vasculitis, central nervous Survival rate Cox regression analysis
  • 相关文献

参考文献19

  • 1Blanco FJ, Gomez-Reino JJ, de la Mata J,et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus, 1998, 7:159-163.
  • 2Huchberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
  • 3ACR Ad Hoc Committee On Neuropsycbiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatrie lupus syndromes. Arthritis Rheum, 1999, 42: 599-608.
  • 4叶任高.内科学 第6版[M].北京:人民卫生出版社,2003.15-31,45-57,169-170.
  • 5谢春,叶任高,张晓林,李幼姬.一种狼疮性肾炎的临床活动性指数[J].中华肾脏病杂志,1997,13(4):206-208. 被引量:84
  • 6Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
  • 7Mok CC, Lee KW, Ho CT, et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford), 2000, 39: 399-406.
  • 8Vyas S, Hidalgo G, Baqi N, et al. Outcome in African- American children of neuropsychiatric lupus and lupus nephritis. Pediatr Nephrol, 2002, 17: 45-49.
  • 9周惠琼,冷晓梅,张奉春.神经精神狼疮患者240例的临床特点、治疗及预后分析[J].中华医学杂志,2006,86(11):771-774. 被引量:33
  • 10王元,顾越英,鲍春德,陈顺乐,周滟,许建荣,钱可久.神经精神狼疮的诊断和治疗[J].中华风湿病学杂志,2004,8(4):230-233. 被引量:17

二级参考文献30

  • 1张奉春,董怡,赵玉华,林禾,姜泉,赵杰.系统性红斑狼疮中枢神经系统病变的诊断及治疗[J].北京医学,1994,16(5):277-280. 被引量:23
  • 2杨岫岩,尹培达.神经精神性红斑狼疮研究进展[J].国外医学(内科学分册),1995,22(7):285-288. 被引量:12
  • 3杨岫岩,尹培达,高翔,刘亚光.系统性红斑狼疮环磷酰胺冲击治疗的最佳间期探讨[J].中华内科杂志,1996,35(4):257-260. 被引量:14
  • 4Stojanovich L, Stojanovich R,Kostich V,et al.Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone(pilot study).Lupus,2003,12:3-7.
  • 5Sanna G,Khamaashta MA,Sanni G.Low-dose pulse cyclophos-phamide in the treatment of neuropsychiatric lupus. Lupus,2003,12:1-2.
  • 6Neuwelt CM,Lacks S,Kaye BR,et al. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med,1995,98:32-41.
  • 7Boumpas DT,Yamada H,Patronas NJ,et al. Pulse cyclophosphamide for severe neuropyschiatric lupus. Q J Med, 1991,81:975-984.
  • 8Sterling GW.Neuropsychiatric lupus. Rheum Dis Clin North Am,1994,20:129-158.
  • 9Anon.The Amercian College of Rheumatology nomenclature and case definitions for neurpsychiatric lupus syndromes. Arthritis Rheum, 1999,42:599-608.
  • 10Sabbadini MG,Manfredi AA,Bozzolo E,et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus,1999,8:9-11.

共引文献148

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部